ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO167

Association of Serum Klotho and Risks of Fractures and Osteoporosis in Patients With and Without CKD

Session Information

Category: Bone and Mineral Metabolism

  • 402 Bone and Mineral Metabolism: Clinical

Authors

  • Chewcharat, Api, Mount Auburn Hospital, Cambridge, Massachusetts, United States
  • Nigwekar, Sagar U., Massachusetts General Hospital, Boston, Massachusetts, United States
Background

Serum soluble Klotho (sKlotho) levels are associated with bone abnormalities in animal models. The extension of these findings to clinical bone outcomes in humans, however, remains controversial.

Methods

We conducted a cross-sectional study among 8,660 US adults aged 40-79 years old in the National Health and Nutrition Examination Survey (NHANES) 2007-2010 and 2013-2014. Fractures were identified based on self-reported hip, wrist, or spine fractures diagnosed by doctors on standardized questionnaires. Osteoporosis was defined as T-score ≤ −2.5 at either femoral neck or lumbar spine. sKlotho was divided into 4 quartiles. We examined the association between sKlotho and risks of fractures and osteoporosis using weighted multivariable logistic regression among participants with and without chronic kidney disease (CKD)

Results

Of 8,660 US adults aged 40-79 years old (847 participants with CKD and 7,813 participants without CKD), 1,042 participants reported history of fractures in either hip, wrist, or spine. Among those who reported a history of fractures, 113 participants were with CKD and 929 participants were without CKD. Median sKlotho among participants with a history of fractures was 788.9 pg/ml vs 804.9 pg/ml among those without a history of fractures. Among non-CKD participants, there was no association between the quartile of sKlotho and the risk of fractures (OR highest vs lowest quartile 0.95, 95%CI [0.75, 1.19], p = 0.64) after adjusting for confounders. Among participants with CKD, after adjusting for confounders, there was no association between the quartile of sKlotho and the risk of fractures (OR highest vs lowest quartile 0.65, 95%CI [0.35, 1.19], p = 0.15) (Table 1). There were no associations between sKlotho and risk of osteoporosis among either CKD or non-CKD (Table 2).

Conclusion

sKlotho does not appear to be a predictor of fractures or osteoporosis in either CKD or non-CKD participants.